Health systems across Europe need to deliver cancer care more quickly, more consistently and with greater focus on patients’ wider needs, according to a new report...
The kick-off trilogue on the Critical Medicines Act (CMA) took place on Monday evening (2 February), with discussions described as constructive. Co-legislators reiterated both their readiness...
EMA’s human medicines committee (CHMP) published the outcomes of their meeting on Friday (30 January). EMA recommended six medicines for approval at its meeting and extended...
The European Parliament’s first debate on MEP Romana Jerković's (S&D, Croatia) draft own-initiative report for an EU cardiovascular disease (CVD) strategy revealed broad support for action,...
At Davos, Canadian Prime Minister Mark Carney finally said what was on everyone’s mind: the global order is dead and the dream of liberalism now rests...
On 19-20 January 2026, a Social Protection Committee Peer Review on Equal Access to goods and services for person with disabilities through reasonable accommodation and accessibility measures was...
Hangzhou Jiuge Biotech’s innovative membrane protein production technology creates collaboration opportunities for the European pharmaceutical industry. (Source: Hangzhou Jiuge Biotech) Amid rising R&D costs and increasing...